Clinical Trials Browser

Prostatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Breast Neoplasms

Salivary Gland Neoplasms, Thyroid Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

Urinary Bladder Neoplasms

Gastroesophageal Adenocarcinoma

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Lung Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms

Breast Neoplasms

Breast Neoplasms

Stomach Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms

HER2-positive Early-stage Breast Cancer

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Osteosarcoma

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Lung Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Esophageal Neoplasms

Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Squamous Cell Carcinoma of Head and Neck

Neoplasms, Stomach Neoplasms

Prostatic Neoplasms

Triple Negative Breast Neoplasms

Hormone Sensitive Prostate Cancer

Stage IV Prostate Adenocarcinoma AJCC v7

Breast Neoplasms

Prostatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Prostatic Neoplasms

Stage I Prostate Adenocarcinoma AJCC v7

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Salivary Gland Neoplasms

Prostatic Neoplasms

Clinical Trials

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

VAROCE

iPRIME

CARABELA

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer

ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

(NeoScorch HN)

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Intravesical Gem/Doce in Patients With NMIBC

Opti-HER2

CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）

TOGAR

RACE

TARMAC

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

EUREKA Study:Phase 2 Study to Optimize Neoadjuvant Therapy in HER2-positive Early-stage Breast Cancer

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer

Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC

COMBI-TED

Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma

Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

DoceRamPem

PDT For Induction Therapy For Head And Neck Cancer

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

SHINE

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer

INTEGRAL

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer

Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer

PIONEER-HN

LUNG-05

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients